The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The supplied identity is internally consistent: SCN9A denotes the orthologue of the mammalian gene encoding the voltage-gated sodium-channel α-subunit NaV1.7, and the organism is the naked mole-rat, Heterocephalus glaber. The UniProt family and domain calls—sodium-channel α-subunit, ion-transport domain, sodium-transport-associated region, and fast-inactivation gate—fit canonical NaV1.7 architecture. No evidence indicated that the symbol referred here to a different gene.
The principal annotation is therefore: a plasma-membrane, voltage-gated, Na+-selective channel that amplifies receptor potentials and helps determine whether peripheral sensory neurons initiate and propagate action potentials. In the naked mole-rat, its best-supported specialized function is in acid nociception: species-specific pore-loop substitutions increase proton-mediated channel inhibition, preventing otherwise excitatory acid-sensitive currents from reaching the action-potential threshold. This contributes substantially to the animal’s unusual behavioral insensitivity to acidic stimuli. However, G9DCX3 is explicitly a sequence fragment, and no retrieved study directly characterized that exact deposited fragment as a complete channel. Full architecture, normal Na+ transport, and detailed localization must consequently be annotated as strong orthology/domain-based inference, whereas the altered acid response is supported by naked-mole-rat-specific physiological and comparative experiments.
Authoritative mammalian literature identifies SCN9A as the gene encoding NaV1.7, while naked-mole-rat literature specifically attributes an acid-adapted NaV1.7 channel to this species. Thus, this is not an ambiguous-symbol substitution involving another organism or another sodium-channel gene. Human disease resources likewise identify SCN9A as “sodium voltage-gated channel alpha subunit 9,” although those human disease associations are contextual rather than direct evidence about G9DCX3 (OpenTargets Search: -SCN9A, smith2020independentevolutionof pages 5-6, dibhajj2013thenav1.7sodium pages 1-2).
The supplied InterPro/domain calls are coherent with this assignment. The ion-transport and sodium-channel α-subunit domains correspond to the voltage-sensing and pore-forming machinery; the inactivation-gate annotation corresponds to the intracellular linker that produces rapid channel inactivation. The reported IQ_SCN5A_C-like and sodium-transport-associated signatures are family-level sequence annotations, not evidence that G9DCX3 is SCN5A or a cardiac NaV1.5 channel.
NaV1.7 is not an enzyme. It is an electrogenic ion channel whose transported substrate is principally Na+. Membrane depolarization activates the channel, allowing Na+ to move down its electrochemical gradient—normally from extracellular fluid into the cell. The resulting inward current further depolarizes the membrane. Rapid inactivation then limits current duration.
In peripheral sensory neurons, NaV1.7 behaves as a threshold channel: its gating allows it to amplify small, subthreshold generator potentials until other sodium channels can support the action-potential upstroke and repetitive firing. This places NaV1.7 between stimulus-transduction channels and propagated electrical signaling rather than making it the primary chemical detector itself (dibhajj2013thenav1.7sodium pages 1-2).
Canonical NaV1.7 is a roughly 1,700–2,000-amino-acid α-subunit containing four homologous domains, DI–DIV. Each domain has six membrane-spanning helices, S1–S6, yielding 24 predicted transmembrane segments in the complete protein. S1–S4 form each voltage-sensing domain; S5–S6 and their intervening extracellular loops form the central pore. The intracellular DIII–DIV linker contains the fast-inactivation apparatus (dibhajj2013thenav1.7sodium pages 1-2).
This canonical model explains the supplied Ion_trans_dom, Na_channel_asu, Na_trans_assoc_dom, and Na_chnl_inactivation_gate annotations. Because G9DCX3 is a fragment, the statement that the deposited sequence itself contains a complete four-domain/24-helix channel would be unjustified. The defensible annotation is that G9DCX3 derives from a protein expected, when full-length, to have this architecture.
NaV1.7 performs its transport function in the plasma membrane. Across mammals it is enriched in peripheral somatic and visceral sensory neurons, olfactory sensory neurons, and sympathetic neurons, with accumulation at peripheral nerve endings. In nociceptors, functionally important pools occur at sensory terminals, along axons, and in neuronal somata, where channel opening controls excitability and action-potential initiation (dibhajj2013thenav1.7sodium pages 1-2).
For naked mole-rat SCN9A, physiological studies place the relevant activity in peripheral nociceptive afferents, including dorsal-root- and trigeminal-system neurons. Nevertheless, the retrieved literature did not provide a dedicated naked-mole-rat immunolocalization or spatial-transcriptomic study uniquely mapping G9DCX3. “Plasma membrane of peripheral sensory neurons, especially nociceptors” is therefore a high-confidence orthology-supported localization, rather than direct localization evidence for the UniProt fragment (smith2020independentevolutionof pages 5-6, browe2020nakedmole‐ratsblind pages 7-8).
Acidic extracellular conditions activate proton-sensitive transduction channels in nociceptive endings. In ordinary mammals, the resulting depolarizing current can recruit NaV1.7, cross action-potential threshold, and transmit an aversive signal centrally. Naked mole-rat NaV1.7 is unusually susceptible to proton inhibition at pH values capable of exciting nociceptors. Consequently, acid can activate upstream proton sensors while simultaneously suppressing the critical voltage-gated amplifier, preventing adequate spike initiation or conduction (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45).
The principal sequence correlate is an extracellular DIV S5–S6-loop EKE motif in naked-mole-rat NaV1.7, replacing the more usual positively charged KKV motif found in human and many other higher-mammalian NaV1.7 channels. This site lies about 20 residues C-terminal to the DEKA selectivity-filter locus. The negative-charge substitution is associated with stronger proton-mediated tonic block (debus2021modelingmechanismsof pages 41-45, harms2017investigationintothe pages 10-14).
Direct species-level observations summarized in the comparative literature include stronger proton inhibition of mechanically evoked naked-mole-rat nociceptor firing than in mouse and absent or strongly diminished behavioral responses to cutaneous acid. Acidic saline and capsaicin evoke little normal C-fibre-associated nocifensive behavior, while formalin responses are reduced; these phenotypes indicate a modified pathway rather than generalized inability to conduct all sensory signals (smith2020independentevolutionof pages 5-6, browe2020nakedmole‐ratsblind pages 7-8).
A human-channel mutagenesis study tested the motif’s causal contribution. Wild-type human NaV1.7 carrying KKV had a proton-inhibition value reported as Ki 5.8 ± 0.05, a Hill coefficient of 1.1 ± 0.06 (n=8), and 37 ± 5% current block at pH 6.0. Introducing the naked-mole-rat-like EKE motif increased tonic proton block (harms2017investigationintothe pages 10-14). These numbers are not direct recordings from G9DCX3; they are cross-species mutational evidence that strengthens the mechanistic interpretation of the naked-mole-rat sequence.
The most precise functional annotation is therefore not “SCN9A causes global painlessness.” Rather, naked-mole-rat SCN9A encodes an acid-sensitive NaV1.7 variant whose proton block reduces conversion of acid-evoked receptor potentials into propagated nociceptor spikes. Other molecular adaptations and circuit properties also contribute to the species’ broader pain phenotype (smith2020independentevolutionof pages 5-6, browe2020nakedmole‐ratsblind pages 7-8).
A pathway-level representation is:
Tissue acidosis/high CO2 → proton-sensitive sensory transducers → local depolarization → NaV1.7-dependent threshold amplification → action potentials in peripheral afferents → spinal/trigeminal nociceptive pathways → pain behavior.
In the naked mole-rat, extracellular protons disproportionately inhibit the NaV1.7 step. This acts as a functional “gate” downstream of acid detection and upstream of central neurotransmission. The adaptation is biologically plausible in crowded subterranean burrows, where elevated CO2 can produce chronic hypercapnia and tissue/environmental acidosis (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45, browe2020nakedmole‐ratsblind pages 7-8).
NaV1.7 also probably supports ordinary sensory-neuron excitability outside acid conditions, as expected from the conserved channel family. The retrieved evidence does not establish that G9DCX3 has unique catalytic activity, unusual ion substrate specificity, or a structural scaffolding role.
The following table distinguishes observations made in naked mole-rat systems from conclusions transferred from better-characterized mammalian orthologues.
| Annotation claim | Evidence specific to naked mole-rat | Evidence from other-species orthologs | Confidence/caveat |
|---|---|---|---|
| Target identity: UniProt G9DCX3 corresponds to Heterocephalus glaber SCN9A / Nav1.7-family sodium channel | Naked mole-rat literature explicitly discusses Nav1.7 encoded by Scn9a/SCN9A as a pain-related sodium channel with species-specific sequence adaptations; reviews of African mole-rat pain evolution identify naked mole-rat Nav1.7 as part of the acid-insensitivity mechanism (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45, browe2020nakedmole‐ratsblind pages 7-8). | Authoritative Nav1.7 review states SCN9A encodes Nav1.7, a voltage-gated sodium-channel alpha subunit central to nociception (dibhajj2013thenav1.7sodium pages 1-2). | High confidence for gene/protein family identity. Caveat: UniProt G9DCX3 is flagged as a fragment, so direct claims about the exact deposited sequence should be limited to family/orthology-consistent features rather than full-length experimental characterization. |
| Primary molecular function: voltage-gated sodium-selective channel supporting Na+ influx during depolarization | Naked mole-rat studies directly support that its Nav1.7 participates in excitability and is unusually susceptible to proton-mediated inhibition under acidic conditions, implying preserved sodium-channel function with altered regulation (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45, browe2020nakedmole‐ratsblind pages 7-8). | Nav1.7 is described as a voltage-gated sodium channel whose pore-forming alpha subunit mediates excitability in sensory neurons; recent structural work maps antagonist binding to human Nav1.7 and supports canonical channel function (dibhajj2013thenav1.7sodium pages 1-2). | High confidence at family/ortholog level; moderate for accession-specific wording. Direct biophysical proof for full-length G9DCX3 itself was not retrieved. |
| Architecture: four homologous domains with 24 transmembrane helices, voltage sensors, pore module, and fast-inactivation elements | Naked mole-rat-specific sources discuss a pore-loop sequence adaptation in Nav1.7 but do not fully re-establish the complete topology experimentally for G9DCX3 (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45, browe2020nakedmole‐ratsblind pages 7-8). | Foundational Nav1.7 review describes a 1,700–2,000 aa channel with four homologous domains (DI–DIV), each containing six transmembrane segments (S1–S6); S1–S4 form voltage-sensing domains and S5–S6 the pore module (dibhajj2013thenav1.7sodium pages 1-2). | High confidence for orthologous Nav1.7 proteins. Caveat: because G9DCX3 is a fragment, full 4-domain/24-TM architecture is an inference from orthology/domain annotation, not direct evidence for the deposited fragment. |
| Subcellular localization: plasma membrane of excitable cells | Naked mole-rat functional studies imply membrane-localized Nav1.7 because proton block alters action-potential conduction in sensory neurons, but direct localization experiments for G9DCX3 were not retrieved (debus2021modelingmechanismsof pages 41-45, browe2020nakedmole‐ratsblind pages 7-8). | Nav1.7 orthologs are established plasma-membrane channels in neurons; reviews and recent structural papers describe Nav1.7 as localized in sensory neurons, especially peripheral afferents/DRG neurons (dibhajj2013thenav1.7sodium pages 1-2). | Moderate-to-high confidence by strong orthology and channel class; direct accession-level localization unavailable. |
| Tissue/cellular expression: dorsal root ganglion nociceptors and peripheral sensory terminals | Naked mole-rat pain literature links Nav1.7 to sensory-neuron acid insensitivity and nociceptor firing, consistent with expression in nociceptive afferents, but the retrieved naked mole-rat evidence did not provide a dedicated localization dataset for SCN9A/G9DCX3 (smith2020independentevolutionof pages 5-6, browe2020nakedmole‐ratsblind pages 7-8). | Nav1.7 is preferentially expressed in peripheral sensory neurons, including DRG nociceptors, and accumulates at nerve endings where it amplifies generator potentials (dibhajj2013thenav1.7sodium pages 1-2). | High confidence for the ortholog; moderate for naked mole-rat direct localization. Avoid overstating as direct evidence for G9DCX3. |
| Sequence adaptation: naked mole-rat Nav1.7 carries an EKE motif where other mammals typically carry KKV | Peer-reviewed work on proton inhibition identifies an EKE motif in naked mole-rat Nav1.7 and reviews cite this motif as a candidate mechanism for acid insensitivity (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45, harms2017investigationintothe pages 10-14). | In human/other higher mammals, the corresponding motif is typically KKV; mutational comparison in human Nav1.7 supports functional importance of this extracellular loop region (harms2017investigationintothe pages 10-14). | High confidence. This is among the strongest naked mole-rat-specific molecular findings. |
| Mechanism under acidic conditions: enhanced proton block of Nav1.7 reduces nociceptor action-potential initiation/conduction | Naked mole-rat reviews summarize direct experiments showing that protons more potently inhibit naked mole-rat Nav1.7 and mechanically evoked nociceptor firing than in mouse; this helps explain behavioral acid insensitivity (smith2020independentevolutionof pages 5-6, debus2021modelingmechanismsof pages 41-45, browe2020nakedmole‐ratsblind pages 7-8). | Quantitatively, human WT Nav1.7 with the mammalian KKV motif showed Ki = 5.8 ± 0.05, Hill coefficient 1.1 ± 0.06 (n=8), and 37 ± 5% block at pH 6.0; introducing the naked-mole-rat-like EKE motif increased tonic proton block, supporting causality of this region (harms2017investigationintothe pages 10-14). | High confidence for the mechanistic model. Caveat: some quantitative numbers retrieved are from human mutagenesis experiments, not directly from G9DCX3 recordings. |
| Biological pathway role: threshold channel in nociception, especially acid pain signaling | Naked mole-rat studies and reviews link Nav1.7 adaptation to failure of acid stimuli to trigger normal pain-related behavior and trigeminal/nociceptor activation, fitting its role in peripheral nociception (smith2020independentevolutionof pages 5-6, browe2020nakedmole‐ratsblind pages 7-8). | Ortholog literature identifies Nav1.7 as a threshold channel that amplifies subthreshold depolarizations in nociceptors; human genetics show gain-of-function causes pain syndromes while loss-of-function causes congenital pain insensitivity (dibhajj2013thenav1.7sodium pages 1-2, OpenTargets Search: -SCN9A). | High confidence for pathway assignment. Naked mole-rat evidence is strongest for acid-pain adaptation, not for every broader SCN9A-associated phenotype known in humans. |
| Real-world and translational relevance: analgesic target and comparative model for pain therapeutics | Naked mole-rat Nav1.7 provides a naturally evolved example of analgesia-relevant channel tuning and is widely cited as inspiration for pain-target discovery (smith2020independentevolutionof pages 5-6, browe2020nakedmole‐ratsblind pages 7-8). | Human SCN9A/Nav1.7 is a major translational target for pain; disease associations include primary erythermalgia, paroxysmal extreme pain disorder, and congenital insensitivity to pain (OpenTargets Search: -SCN9A). Reviews of human clinical development note limited efficacy of several small molecules and growing interest in gene-therapy approaches; one reported platform showed about 50% reduction in SCN9A expression in preliminary in-vitro work (dormer2023areviewof pages 5-6). | High confidence for translational importance. Caveat: clinical/therapeutic evidence is human-focused and should not be represented as direct functional validation for naked mole-rat G9DCX3. |
Table: This table separates direct evidence for naked mole-rat SCN9A/Nav1.7 from ortholog-based inference relevant to UniProt G9DCX3. It is useful for functional annotation because G9DCX3 is a fragment and many mechanistic details come from cross-species Nav1.7 research rather than direct experiments on this accession.
The decisive organism-specific SCN9A work predates 2023. Searches of 2023–2024 literature identified extensive new research on human or mouse NaV1.7, but little direct new characterization of naked-mole-rat G9DCX3. Recent research should therefore update structural and translational context without being misrepresented as species-specific validation.
Human genetics strongly validates the pathway: SCN9A gain-of-function variants are associated with severe pain syndromes, whereas loss-of-function variants cause channelopathy-associated congenital insensitivity to pain. Current disease resources associate SCN9A with primary erythermalgia, paroxysmal extreme pain disorder, congenital pain insensitivity, and hereditary sensory/autonomic neuropathy (OpenTargets Search: -SCN9A, dibhajj2013thenav1.7sodium pages 1-2). These associations demonstrate the conserved importance of NaV1.7 in pain, but they do not imply that naked mole-rats have those human diseases.
A 2023 review concluded that NaV1.7 remains a compelling, genetically validated non-opioid analgesic target, while emphasizing the limited effectiveness of several small-molecule programs. Programs discussed included lacosamide, PF-05089771, vixotrigine, and GDC-0276 in early clinical development for small-fibre neuropathy, diabetic peripheral neuropathy, or trigeminal neuralgia. The expert interpretation was that subtype selectivity, adequate target engagement, and reproducing the profound phenotype of genetic channel loss remain major challenges (dormer2023areviewof pages 5-6).
The same review highlighted transcriptional or gene-therapy approaches, including CRISPR-based repression and plasmid systems. In preliminary in-vitro work, one SMARTmid platform reduced SCN9A expression by approximately 50%; mouse studies reportedly reduced tactile allodynia and thermal hyperalgesia without detectable motor impairment. These are preclinical findings, not approved therapies and not naked-mole-rat experiments (dormer2023areviewof pages 5-6).
The naked-mole-rat mechanism suggests an additional design principle: analgesia may be achieved not only by complete channel blockade but by engineering state- or microenvironment-dependent inhibition, such as preferential suppression in acidic inflamed tissue. However, translating the EKE/proton-block mechanism would require demonstrating selectivity, reversibility, preserved protective pain, and absence of effects in olfactory or autonomic neurons.
Molecular function: voltage-gated sodium-selective channel activity; depolarization-activated inward Na+ conductance; threshold amplification in excitable sensory membranes.
Biological process: regulation of membrane potential and sensory-neuron excitability; initiation/propagation of peripheral action potentials; nociceptive signaling, with a particularly well-supported role in acid nociception.
Cellular component: integral component of the plasma membrane, inferred to localize to sensory-neuron somata, axons, and peripheral endings.
Naked-mole-rat specialization: an extracellular pore-loop EKE motif enhances proton-dependent inhibition of NaV1.7, reducing acid-evoked nociceptor firing and contributing to acid-pain insensitivity.
Evidence qualifier: family identity and acid adaptation have strong species-specific support; complete topology, detailed localization, and standard electrophysiological properties are mainly inferred from mammalian orthology because G9DCX3 is a fragment and has not itself been comprehensively characterized.
References
(OpenTargets Search: -SCN9A): Open Targets Query (-SCN9A, 6 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(smith2020independentevolutionof pages 5-6): Ewan St. John Smith, Thomas J. Park, and Gary R. Lewin. Independent evolution of pain insensitivity in african mole-rats: origins and mechanisms. Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology, 206:313-325, Mar 2020. URL: https://doi.org/10.1007/s00359-020-01414-w, doi:10.1007/s00359-020-01414-w. This article has 28 citations.
(dibhajj2013thenav1.7sodium pages 1-2): Sulayman D. Dib-Hajj, Yang Yang, Joel A. Black, and Stephen G. Waxman. The nav1.7 sodium channel: from molecule to man. Nature Reviews Neuroscience, 14:49-62, Dec 2013. URL: https://doi.org/10.1038/nrn3404, doi:10.1038/nrn3404. This article has 744 citations and is from a highest quality peer-reviewed journal.
(browe2020nakedmole‐ratsblind pages 7-8): Brigitte M. Browe, Emily N. Vice, and Thomas J. Park. Naked mole‐rats: blind, naked, and feeling no pain. The Anatomical Record, 303:77-88, Nov 2020. URL: https://doi.org/10.1002/ar.23996, doi:10.1002/ar.23996. This article has 33 citations.
(debus2021modelingmechanismsof pages 41-45): Karlien Y. Debus. Modeling mechanisms of nociception using the african mole-rat family. ArXiv, Jan 2021. URL: https://doi.org/10.17169/refubium-29110, doi:10.17169/refubium-29110. This article has 0 citations.
(harms2017investigationintothe pages 10-14): Elisa Harms, Carsten Stoetzer, Thomas Stueber, Andrias O. O’Reilly, and Andreas Leffler. Investigation into the role of an extracellular loop in mediating proton-evoked inhibition of voltage-gated sodium channels. Neuroscience Letters, 661:5-10, Nov 2017. URL: https://doi.org/10.1016/j.neulet.2017.09.039, doi:10.1016/j.neulet.2017.09.039. This article has 10 citations and is from a peer-reviewed journal.
(dormer2023areviewof pages 5-6): Anton Dormer, Mahesh Narayanan, Jerome Schentag, Daniel Achinko, Elton Norman, James Kerrigan, Gary Jay, and William Heydorn. A review of the therapeutic targeting of scn9a and nav1.7 for pain relief in current human clinical trials. Journal of Pain Research, 16:1487-1498, May 2023. URL: https://doi.org/10.2147/jpr.s388896, doi:10.2147/jpr.s388896. This article has 64 citations and is from a peer-reviewed journal.